ライフサイエンスコーパス: internal mammary artery

1 pterins (P<0.05 for both saphenous veins and internal mammary arteries).

2 to be expressed in human saphenous vein and internal mammary artery.

3 d CABG on cardiopulmonary bypass with a left internal mammary artery.

4 er from lower patency rates compared to left internal mammary artery.

5 determined in segments of saphenous vein and internal mammary artery.

6 human radial artery behaves similarly to the internal mammary artery.

7 othelial function and O(2)(.-) generation in internal mammary arteries.

8 ilability and reduced O(2)(.-) generation in internal mammary arteries.

9 In rings of intact internal mammary artery, 1 microM of atrial natriuretic

10 Among the 796 CABG grafts (345 left internal mammary artery, 12 right internal mammary arter

11 was greater (EC(50)=33+/-7 nmol/L) than the internal mammary artery (203+/-32 nmol/L) or saphenous v

12 was greater in radial artery (39+/-5%) than internal mammary artery (23+/-6%) or saphenous vein (5+/

13 8.3+/-1.4 pmol/mg protein) compared with the internal mammary artery (3.5+/-1.3 pmol/mg protein) or s

14 ne (86+/-10%) was significantly greater than internal mammary artery (56+/-9%) or saphenous vein (11+

15 /-1.7 pmol/mg protein) was also greater than internal mammary artery (6.2+/-0.3 pmol/mg protein) or s

16 h was significantly lower than that for left internal mammary arteries (90.3%, P<0.0001) or saphenous

17 o experiments with human saphenous veins and internal mammary arteries, adiponectin induced Akt-media

18 vivo experiments with human saphenous veins/internal mammary arteries and adipose tissue, we demonst

19 Segments of saphenous vein and internal mammary artery and confluent smooth muscle cell

20 ning; conduit selection, including bilateral internal mammary artery and radial artery use; intraoper

21 Segments of internal mammary artery and saphenous vein from patients

22 ry grafts have lower patency rates than left internal mammary artery and saphenous vein grafts.

23 Segments of internal mammary artery and saphenous vein were obtained

24 In separate experiments, segments of internal mammary artery and saphenous vein were obtained

25 Segments of internal mammary artery and saphenous vein were obtained

26 rd approval and patient consent, segments of internal mammary artery and saphenous vein were obtained

27 perties of the radial artery to those of the internal mammary artery and saphenous vein.

28 oing coronary artery bypass grafting with an internal mammary artery and with 1 to 4 vein grafts were

29 rplasia, we incubated human saphenous veins, internal mammary arteries, and radial arteries (n=6, 8,

30 Matched segments of radial artery, internal mammary artery, and saphenous vein (n=24 patien

31 uscle cells cultured from saphenous vein and internal mammary artery, bacterial lipopolysaccharide tr

32 monstrated that patients receiving bilateral internal mammary artery (BIMA) conduits during coronary

33 the potential survival benefit of bilateral internal mammary artery (BIMA) grafting in comparison wi

34 dies have shown the superiority of bilateral internal mammary artery (BIMA) grafting over single inte

35 els in plasma and in saphenous vein (but not internal mammary artery) but also increased levels of th

36 Coronary stenting (STENT) and left internal mammary artery bypass grafting of the LAD (LIMA

37 coronary revascularization ranges from left internal mammary artery bypass grafting via sternotomy a

38 The superior long-term patency of internal mammary artery coronary bypass grafts compared

39 In human internal mammary arteries, depressed endothelium-depende

40 udy is to test the effect of permanent right internal mammary artery device closure on coronary colla

41 Permanent right internal mammary artery device closure seems to augment

42 ow-up examination 6 weeks after distal right internal mammary artery device closure.

43 graft and 86.9% of vein graft, and 91.6% of internal mammary artery distal anastomotic sites had <50

44 strong case for much wider use of bilateral internal mammary arteries during CABG, and off-pump CABG

45 Finally, in human internal mammary artery, endothelial GR is found to be h

46 tion of arterial conduits, in particular the internal mammary arteries, for coronary bypass surgery w

47 kinin were determined in saphenous veins and internal mammary arteries from 117 patients undergoing C

48 Finally, segments of internal mammary arteries from 26 patients were used in

49 n was quantified in both saphenous veins and internal mammary arteries from 45 diabetic and 45 matche

50 ere is evidence that patients who receive an internal mammary artery graft (IMA) during coronary arte

51 tal and surgeon effects, and care processes (internal mammary artery graft and perioperative medicati

52 urvival was better for patients receiving an internal mammary artery graft than those receiving vein

53 al benefits associated with the durable left internal mammary artery graft to the left anterior desce

54 active search of associated CAD, wide use of internal mammary artery graft, and vigorous efforts for

55 Internal mammary artery grafting was adopted slowly and

56 However, it was similar to that in new internal mammary artery grafts (30.0%).

57 ed the same number of total grafts but fewer internal mammary artery grafts (72% versus 85%, P<0.01),

58 Frequently, these patients have patent internal mammary artery grafts and require isolated inte

59 Internal mammary artery grafts were associated with impr

60 ension, diabetes, poststernotomy septicemia, internal mammary artery harvest, use of intra-aortic bal

61 all left anterior thoracotomy using the left internal mammary artery has been performed in some cente

62 on of antibiotic prophylaxis, and use of the internal mammary artery have been advocated as quality i

63 It has been established that internal mammary arteries (IMA) are resistant to the dev

64 It is limited to patients receiving an internal mammary artery (IMA) graft and is apparent earl

65 A single internal mammary artery (IMA) graft has proven survival

66 The influence of an internal mammary artery (IMA) graft on long-term outcome

67 after percutaneous revascularization of the internal mammary artery (IMA) graft.

68 d consecutive miniCABG cases performed using internal mammary artery (IMA) grafting +/- coronary sten

69 was to assess the pattern of the adoption of internal mammary artery (IMA) grafting in the United Sta

70 linical advantages of using routine multiple internal mammary artery (IMA) grafts for coronary artery

71 m patency of saphenous vein grafts (SVG) and internal mammary artery (IMA) grafts.

72 ronary artery bypass graft surgeries with an internal mammary artery (IMA) have better long-term surv

73 The internal mammary artery (IMA) is considered the gold-sta

74 Because the internal mammary artery (IMA) is often visualized during

75 The internal mammary artery (IMA) is the preferred conduit f

76 herectomy (DCA) and control samples from the internal mammary artery (IMA) of 7 patients undergoing b

77 gate CMV infection in human coronary artery, internal mammary artery (IMA), and saphenous vein (SV).

78 become a preferable graft, secondary to the internal mammary artery (IMA).

79 Internal mammary arteries (IMAs) and saphenous veins (SV

80 Segments of internal mammary arteries (IMAs) with their perivascular

81 rginine methyl ester-inhibitable O(2)(.-) in internal mammary arteries independently of low-density l

82 s a new surgical technique by which the left internal mammary artery is anastomosed under direct visu

83 g (CABG), the combined use of left and right internal mammary arteries (LIMA and RIMA) - collectively

84 aft surgery (CABG); all received RA and left internal mammary artery (LIMA) grafts.

85 Use of the left internal mammary artery (LIMA) in multivessel coronary a

86 e frequency of early occlusion when the left internal mammary artery (LIMA) is anastomosed to the lef

87 ECAB of the LAD was performed using the left internal mammary artery (LIMA).

88 teine were determined in saphenous veins and internal mammary arteries obtained during surgery.

89 expression of arginase was determined in the internal mammary artery of patients undergoing bypass su

90 rnal mammary artery/SV (n=589) and bilateral internal mammary artery only (n=271) had improved 15-yea

91 Finally, in tissue segments from either internal mammary artery or saphenous vein, both forskoli

92 ion of radial artery is greater than that of internal mammary artery or saphenous vein.

93 hUII did not contract these arteries, internal mammary arteries, or either type of vein, but i

94 We describe a pedicled internal mammary artery osteomyocutaneous chimeric flap

95 n rate of 33.7%, compared with 4.8% for left internal mammary arteries (P<0.0001), and had a severe s

96 ous vein grafts (P=0.0003) and 4.8% for left internal mammary arteries (P<0.0001).

97 ears [P<0.001]), and patients with bilateral internal mammary artery/radial artery (n=147) and LIMA/r

98 (345 left internal mammary artery, 12 right internal mammary artery/radial, and 439 veins), 97 (12%)

99 n A (native coronary perfusion plus the left internal mammary artery), reperfusion B (saphenous vein

100 Segments of internal mammary artery responded in a similar manner.

101 .3+/-0.4%, 1.4+/-1.0%, and 3.8+/-0.8% in the internal mammary arteries, saphenous veins, and normal c

102 ults-Small subcutaneous resistance arteries, internal mammary arteries, saphenous veins, and small su

103 upling were quantified in saphenous vein and internal mammary artery segments.

104 ry (BIMA) grafting in comparison with single internal mammary artery (SIMA) grafting has been emphasi

105 l mammary artery (BIMA) grafting over single internal mammary artery (SIMA) grafting in select popula

106 -term survival than those receiving a single internal mammary artery (SIMA), data on risk of repeat r

107 Internal mammary artery specimens were obtained from pat

108 antified in perivascular (saphenous vein and internal mammary artery) subcutaneous and mesothoracic a

109 MultArt subgroups with bilateral internal mammary artery/SV (n=589) and bilateral interna

110 f important survival benefits with bilateral internal mammary arteries, there is no evidence for clin

111 ABG) based on experience with using the left internal mammary artery to bypass the left anterior desc

112 a limited left anterior thoracotomy and left internal mammary artery to LAD grafting without the use

113 ements from Phase I in aspirin prescription, internal mammary artery use, and duration of intubation

114 The use of internal mammary artery was marginally lower in blacks t

115 The left internal mammary artery was used in 62 patients, and 61

116 average of 2.4 grafts was placed, and a new internal mammary artery was used on 47 occasions.

117 The left internal mammary artery was used to preferentially graft

118 Samples of saphenous veins and internal mammary arteries were collected from 219 patien

119 scle cells, cultured from saphenous vein and internal mammary artery, were exposed to 20 micrograms/m